Concepedia

Current state of clinical trials in breast cancer brain metastases

Jawad Fares, Deepak Kanojia, Álex Cordero, Aida Rashidi, Jason Miska, Charles W. Schwartz, Solomiia Savchuk, Atique U. Ahmed, Irina V. Balyasnikova, Massimo Cristofanilli,

Neuro-Oncology Practice · 2019 · 27 citations · 38 references

DOI Full text

Open access

Abstract

The low number of trials and accrual numbers, the lack of diversity, and the scarcity of published results represent the main troubles in clinical BCBM research. Optimization of BCBM trials is necessary to achieve effective therapies.

References

38

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 28.6K citations

Surgical Oncology, Recist Guideline, Medicine +9

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

Sandra M. Swain, José Baselga, Sung‐Bae Kim et al. · New England Journal of Medicine · 2015 · 2.1K citations · Full text

Genes that mediate breast cancer metastasis to the brain

Paula D. Bos, Xiang H.-F. Zhang, Cristina Nadal et al. · Nature · 2009 · 1.9K citations · Full text

Breast Cancer Metastasis, Medicine, Cancer Genomics +5

Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma

Leo J. Schouten, Joost Rutten, Hans A. M. Huveneers et al. · Cancer · 2002 · 1.6K citations · Full text

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

Hussein A. Tawbi, Peter Forsyth, Alain P. Algazi et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text